Brazil's health regulator Anvisa said Bharat Biotech's Covaxin did not meet its manufacturing standards. The Brazilian government previously signed a contract to buy 20 million doses. Bharat said in a statement that they would appeal the decision. (The Rio Times) COVID-19 pandemic in BrazilCOVID-19 pandemic in South AmericaCOVID-19 pandemic link embed save